Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. A. Nabatchikova"'
Autor:
S. V. Gavrisheva, D. T. Abdurakhmanov, N. M. Bulanov, E. L. Tanashhuk, T. P. Rozina, E. N. Nikulkina, S. Yu. Milovanova, E. A. Nabatchikova, A. L. Filatova, E. E. Starostina, T. N. Krasnova, S. V. Moiseev
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 2, Pp 181-187 (2023)
Objective – to evaluate the long-term outcomes of HCV eradication with direct-acting antivirals (DAAs) in patients with hepatitis C-associated cryoglobulinemic vasculitis (HCV-CV)Materials and methods. We retrospectively assessed 48 patients with H
Externí odkaz:
https://doaj.org/article/f4f65245779c4f3bb097a0d2bfd5bf80
Autor:
E. A. Nabatchikova, D. T. Abdurakhmanov, E. N. Nikulkina, T. P. Rozina, E. L. Tanaschuk, S. V. Moiseev
Publikováno v:
Сеченовский вестник, Vol 11, Iss 1, Pp 26-37 (2020)
Direct-acting antivirals (DAAs) therapy is associated with fibrosis regression in patients with hepatitis C virus liver cirrhosis.Aim. To study the dynamic of liver fibrosis in cirrhotic patients with a DAAs-induced sustained virological response (SV
Externí odkaz:
https://doaj.org/article/31caeda701c84ba0b30ab2cbe632d28b
Autor:
E. A. Nabatchikova, D. T. Abdurakhmanov, E. N. Nikulkina, T. P. Rozina, E. L. Tanaschuk, N. V. Nikiforova, V. S. Adonyeva, S. V. Moiseev
Publikováno v:
Терапевтический архив, Vol 92, Iss 2, Pp 34-42 (2020)
Aim.To study liver function and portal hypertension, incidence and risk factors of liver-related complications, including hepatocellular carcinoma (HCC), in patients with HCV-related liver cirrhosis achieved sustained virologic response (SVR) after d
Externí odkaz:
https://doaj.org/article/2b5f0849d5eb4a2ba4fd5b3510043c30